Omega-3 fatty acids vs. cardiac disease - The contribution of the omega-3 index

Cellular and Molecular Biology

Volumn 56, Issue 1, 2010, Pages 93-101

  Von Schacky, C ^a,b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Omegametrix GmbH   (Germany)

Author keywords

Congestive heart failure; Coronary artery disease; Docosahexaenoic acid; Eicosapentaneoic acid; Omega 3 index; Sudden cardiac death

Indexed keywords

DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID;

ARTICLE; CARDIOVASCULAR RISK; DIETARY INTAKE; ERYTHROCYTE; FATTY ACID BLOOD LEVEL; HEART DEATH; HEART DISEASE; HUMAN; INTERVENTION STUDY; LARGE SCALE PRODUCTION; NUTRITIONAL PARAMETERS; OMEGA 3 INDEX; RISK FACTOR; SUDDEN DEATH; BLOOD; DIET SUPPLEMENTATION; MORTALITY; RANDOMIZED CONTROLLED TRIAL;

DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FATTY ACIDS, OMEGA-3; HEART DISEASES; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS;

EID: 77953629745     PISSN: 01455680     EISSN: 1165158X     Source Type: Journal    
DOI: 10.1170/T882     Document Type: Article

References (53)

1. Albert, C.M., Campos, H., Stampfer, M.J., Ridker, P.M., Manson, J.E., Willett, W.C., and Ma, J., Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N. Engl. J. Med. 2002, 346: 1113-1118
2. Block, R.C., Harris, W.S., Reid, K.J., Sands, S.A., and Spertus, J.A., EPA and DHA in blood cell membranes from acute coronary syndrome patients and controls. Atherosclerosis. 2008; 197: 821-828
3. Crouse, J.R,, 3rd, Raichlen, J.S., Riley, W.A., Evans, G.W., Palmer, M.K., O'Leary, D,H,, Grobbee, D.E., and Bots, M.L., METEOR Study Group., Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial. J. Am. Med. Assoc. 2007, 297: 1344-1353
4. Gissi-HF Investigators, Tavazzi, L., Maggioni, A.P., Marchioli, R., Barlera, S., Franzosi, M.G., Latini, R., Lucci, D., Nicolosi, G.L., Porcu, M., and Tognoni, G., Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomized, double-blind, placebo-controlled trial. Lancet 2008, 72: 1223-1230
5. Harris, W.S. The omega-3 index as a risk factor for coronary heart disease. Am. J. Clin. Nutr. 2008, 87: 1997S-2002S
6. Harris, W.S., Poston, W.C., and Haddock, C.K., Tissue n- 3 and n-6 fatty acids and risk for coronary heart disease events. Atherosclerosis. 2007, 193: 1-10
7. Harris, W.S., Sands, S.A., Windsor, S.L., Ali, H.A., Stevens, T.L., Magalski, A., Porter, C.B., and Borkon, A.M., Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: correlation with erythrocytes and response to supplementation. Circulation. 2004, 110: 1645-1649
8. Harris, W.S., and von Schacky, C., The Omega-3 Index: a new risk factor for death from coronary heart disease ? Prev. Med. 2004, 39: 212-220
9. Harris, W.S., von Schacky, C., and Park, Y., Establishing uniform analytical methods for RBC omega-3 fatty acids: an intercontinental pilot study. ISSFAL 2008, Abstract book page 78
10. Hooper, L., Thompson, R.L., Harrison, R.A., Summerbell, C.D., Ness, A.R., Moore, H.J., Worthington, H.V., Durrington, P.N., Higgins, J.P., Capps, N.E., Riemersma, R.A., Ebrahim, S.B., and Davey Smith, G., Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review. Br. Med. J. 2006, 332: 752-760
11. Hu, F.B., Bronner, L., Willett, W.C., Stampfer, M.J., Rexrode, K.M., Albert, C.M., Hunter, D., and Manson. J.E., Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. J. Am. Med. Assoc.. 2002, 287: 1815-1821
12. Iso, H., Kobayashi, M., Ishihara, J., Sasaki, S., Okada, K., Kita, Y., Kokubo, Y., Tsugane, S., and JPHC Study Group., Intake of fish and n3 fatty acids and risk of coronary heart disease among Japanese: the Japan Public Health Center-Based (JPHC) Study Cohort I. Circulation 2006, 113: 195-202
13. Itomura, M., Fujioka, S., Hamazaki, K., Kobayashi, K., Nagasawa, T., Sawazaki, S., Kirihara, Y., and Hamazaki, T.. Factors influencing EPA+DHA levels in red blood cells in Japan. In Vivo. 2008, 22: 131-135
14. LaRosa, J.C., Grundy, S.M., Waters, D.D., Shear, C., Barter, P., Fruchart, J.C., Gotto, A.M., Greten, H., Kastelein, J.J.P., Shepherd, J., and Wenger, N.K., Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease. N. Engl. J. Med. 2005, 352: 1425-1435
15. León, H., Shibata, M.C., Sivakumaran, S., Dorgan, M., Chatterley, T., and Tsuyuki, R.T., Effect of fish oil on arrhythmias and mortality: systematic review. Br. Med. J. 2008, 337:a2931
16. Macchia, A., Levantesi, G., Franzosi, M.G., Geraci, E., Maggioni, A.P., Marfisi, R., Nicolosi, G.L., Schweiger, C., Tavazzi, L., Tognoni, G., Valagussa, F., Marchioli, R., and GISSI-Prevenzione Investigators., Left ventricular systolic dysfunction, total mortality, and sudden death in patients with myocardial infarction treated with n-3 polyunsaturated fatty acids. Eur. J. Heart. Fail. 2005, 7: 904-909
17. Marchioli, R., Barzi, F., Bomba, E., Chieffo, C., Di Gregorio, D., Di Mascio, R., Franzosi, M.G., Geraci, E., Levantesi, G., Maggioni, A.P., Mantini, L., Marfisi, R.M., Mastrogiuseppe, G., Mininni, N., Nicolosi, G.L., Santini, M., Schweiger, C., Tavazzi, L., Tognoni, G., Tucci, C., Valagussa, F., and GISSI-Prevenzione Investigators., Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction. Time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nelĺInfarcto Miocardio (GISSI)-Prevenzione. Circulation 2002. 105: 1897-1903
18. Metcalf, R.G., James, M.J., Gibson, R.A., Edwards, J.R., Stubberfield, J., Stuklis, R., Roberts-Thomson, K., Young, G.D., and Cleland, L.G., Effects of fish-oil supplementation on myocardial fatty acids in humans. Am. J. Clin. Nutr. 2007, 85: 1222-1228.
19. Mozaffarian, D. and Rimm, E.B., Fish intake, contaminants, and human health: evaluating the risks and the benefits. J. Am. Med. Assoc. 2006, 296: 1885-1899
20. Plourde, M., and Cunnane, S.C., Extremely limited synthesis of long chain polyunsaturates in adults: implications for their dietary essentiality and use as supplements. Appl. Physiol. Nutr. Metab. 2007, 32: 619-634
21. Sacks, F.M., Pfeffer, M.A., Moye, L.A., Rouleau, J.L., Rutherford, J.D., Cole, T.G., Brown, L., Warnica, J.W., Arnold, J.M., Wun, C.C., Davis, B.R., and Braunwald E.,The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N. Engl. J. Med. 1996, 335 14: 1001-1009
22. Saito, Y., Yokoyama, M., Origasa, H., Matsuzaki, M., Matsuzawa, Y., Ishikawa, Y., Oikawa, S., Sasaki, J., Hishida, H., Itakura, H., Kita, T., Kitabatake, A., Nakaya, N., Sakata, T., Shimada, K., Shirato, K., and JELIS Investigators, Japan., Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS). Atherosclerosis. 2008, 200: 135-40
23. Sands, S.A., Reid, K.J., Windsor, S.L., and Harris, W.S.,The impact of age, body mass index, and fish intake on the EPA and DHA content of human erythrocytes. Lipids. 2005; 40: 343-7
24. Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994, 344: 1383-1389
25. Sekikawa, A., Curb, J.D., Ueshima, H., El-Saed, A., Kadowaki, T., Abbott, R.D., Evans, R.W., Rodriguez, B.L., Okamura, T., Sutton-Tyrrell, K., Nakamura, Y., Masaki, K., Edmundowicz, D., Kashiwagi, A., Willcox, B.J., Takamiya, T., Mitsunami, K., Seto, T.B., Murata, K., White, R.L., Kuller, L.H., and ERA JUMP (Electron-Beam Tomography, Risk Factor Assessment Among Japanese and U.S. Men in the Post-World War II Birth Cohort) Study Group. Marine-derived n-3 fatty acids and atherosclerosis in Japanese, Japanese-American, and white men: a cross-sectional study. J. Am. Coll. Cardiol. 2008, 52: 417-24
26. Siscovick D.S., Raghunathan, T.E., King, I., Weinmann, S., Wicklund, K.G., Albright, J., Bovbjerg, V., Arbogast, P., Smith, H., and Kushi, L.H.. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the riskof primary cardiac arrest. J. Am. Med. Assoc. 1995, 275: 836-837
27. Smith, S.C. Jr., Allen, J., Blair, S.N., Bonow, R.O., Brass, L.M., Fonarow, G.C., Grundy, S.M., Hiratzka, L., Jones, D., Krumholz, H.M., Mosca, L., Pasternak, R.C., Pearson, T., Pfeffer, M.A., Taubert, K.A. and AHA/ACC; National Heart, Lung, and Blood Institute. AHA/ACC Guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update. Circulation. 2006, 113: 2363-2372
28. Smulders, Y.M., Thijs, A., and Twisk, J.W., New cardiovascular risk determinants do exist and are clinically useful. Eur. Heart. J. 2008, 29: 436-440
29. Sun, Q.,, Ma, J., Campos, H., Rexrode, K.M., Albert, C.M., Mozaffarian, D., and Hu, F.B., Blood concentrations of individual long-chain n-3 fatty acids and risk of nonfatal myocardial infarction. Am. J .Clin. Nutr. 2008, 88: 216-223
30. Ueeda, M., Doumei, T., Takaya, Y., Shinohata, R., Katayama, Y., Ohnishi, N., Takaishi, A., Miyoshi, T., Hirohata, S., and Kusachi S. Serum N-3 polyunsaturated fatty acid levels correlate with the extent of coronary plaques and calcifications in patients with acute myocardial infarction. Circ. J. 2008, 72: 1836-1843
31. Ueshima, H., Explanation for the Japanese paradox: Reduction of increase in coronary heart disease and reduction in stroke. J. Atheroscl. Thromb. 2007, 14: 278-286
32. Van der Werf , F., Bax, J., Betriu, A., Blomstrom-Lundquist, C., Crea, F., Falk, F., Filippattos, G., Fox, K., Huber, K., Kastrati, A., Rosengren, A., Steg, P.G., Tubaro, M., Verheugt, F., Weidinger, F., and Weis, M., The task force on the management of ST-segment elevation acute myocardial infarction of the European Society for Cardiology. Management of acute myocardial infarction in patients presenting with persistent ST-elevation. Eur. Heart J. 2008, 29: 2909-2945
33. von Schacky, C., Use of red blood cell fatty acid analysis as biomarkers in cardiac disease. Biomarkers Med. 2009, in press
34. von Schacky, C., Fischer, S., and Weber, P.C., Long term effects of dietary marine ω-3 fatty acids upon plasma-and cellular lipids, platelet function and eicosanoid formation in humans. J. Clin. Invest. 1985, 76: 1626-1631
35. von Schacky, C., Siess, W., Fischer, S., and Weber, P.C., A comparative study of eicosapentaenoic acid metabolism by human platelets in vivo and in vitro. J. Lipid Res. 1985, 26: 457-464
36. von Schacky, C., and Weber, P.C., Metabolism and effects on platelet function of the purified eicosapentaenoic and docosahexaenoic acids in humans. J. Clin. Invest. 1985, 76: 2446-2450
37. Wang, C, Harris, W.S., Chung, M., Lichtenstein, A.H., Balk, E.M., Kupelnick, B., Jordan, H.S., and Lau, J., n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am. J. Clin. Nutr. 2006, 84: 5-17
38. Wang, T.J., New cardiovascular risk factors exist, but are they clinically useful ? Eur. Heart J. 2008, 29: 441-444
39. Yamagishi, K., Iso, H., Date, C., Fukui, M., Wakai, K., Kikuchi, S., Inaba, Y., Tanabe, N., Tamakoshi, A., and Japan Collaborative Cohort Study for Evaluation of Cancer Risk Study Group. Fish, omega-3 polyunsaturated fatty acids, and mortality from cardiovascular diseases in a nationwide community-based cohort of Japanese men and women the JACC (Japan Collaborative Cohort Study for Evaluation of Cancer Risk) Study. J. Am. Coll. Cardiol. 2008, 52: 988-996
40. Yokoyama, M., Origasa, H., Matsuzaki, M., Matsuzawa, Y., Saito, Y., Ishikawa, Y., Oikawa, S., Sasaki, J., Hishida, H., Itakura, H., Kita, T., Kitabatake, A., Nakaya, N., Sakata, T., Shimada, K., Shirato, K., and Japan EPA lipid intervention study (JELIS) Investigators. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 2007, 369: 1090-1098
41. Zipes, D.P, Camm, A.J., Borggrefe, M., Buxton, A.E., Chaiman, B., Fromer, M., Gregoratos, G., Klein, G., Moss, A.J., Myerburg, R.J., Priori, S.G., Quinones, M.A., D.M., Silka, M.J., Tracy, C., Blanc, J.J., Budaj, A., Dean, V., Deckers, J.W., Despres, C., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J.L., Zamorano, J.L., Smith, S.C. Jr,, Jacobs, A.K., Adams, C.D., Antman, E.M., Anderson, J.L., Hunt, S.A., Halperin, J.L., Nishimura, R., Ornato,J.P., Page, R.L., Riegel, B., American College of Cardiology/American Heart Association Task Force, European Society of Cardiology Committee for Practice Guidelines, and European Heart Rhythm Association and the Heart Rhythm Society, ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death - executive summary: a report of the American College of Cardiology / American Heart Association Task Force and the European Society forCardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Eur. Heart J. 2006, 27: 2099-2140
42. Andersen, V.L., Vogt, J., Obel, T., Christensen, J.H., Schmidt, E.B., The effect of n-3 fatty acids on plasma myeloperoxidase levels in healthy adults. Cell. Mol. Biol. 2010, 56(1): 3-9.
43. Andreasen, J. J., Aardestrup, I. V., Eschen, R. B., Obel, T., Lundbye-Christensen, S., Schmidt, E. B., Fatty acid composition of the internal mammary artery in relation to dietary intake of marine n-3 polyunsaturated fatty acids and association with flow-mediated vasodilation. Cell. Mol. Biol. 2010, 56(1): 10-17
44. Arnesen, H., Seljeflot, I., Studies on very long chain marine n-3 fatty acids in patients with atherosclerotic heart disease with special focus on mechanisms, dosage and formulas of supplementation. Cell. Mol. Biol. 2010, 56(1): 18-27
45. Calder, P.C., Yaqoob, P., Omega-3 (n-3) fatty acids, cardiovascular disease and stability of atherosclerotic plaques. Cell. Mol. Biol. 2010, 56(1): 28-37
46. Petersen, M.M., Eschen, R.B., Aardestrup, I., Obel, T., Schmidt, E.B., Flow-mediated vasodilation and dietary intake of n-3 polyunsaturated acids in healthy subjects. Cell. Mol. Biol. 2010, 56(1): 38-44
47. Eschen, O., Christensen, J.H., La rovere, M.T., Romano, P., Sala, P., Schmidt, E.B., Effects of marine n-3 fatty acids on circulating levels of soluble adhesion molecules in patients with chronic heart failure. Cell. Mol. Biol. 2010, 56(1): 45-51
48. Isherwood, C, Wong, M., Jones, W.S., Davies, I.G., Griffin, B.A., lack of effect of cold water prawns on plasma cholesterol and lipoproteins in normo-lipidaemic men. Cell. Mol. Biol. 2010, 56(1): 52-58
49. Massaro, M., Scoditti, E., Carluccio, M. A., Campana, M. C, De caterina, R., Omega-3 fatty acids, inflammation and angiogenesis: basic mechanisms behind the cardioprotective effects of fish and fish oils. Cell. Mol. Biol. 2010, 56(1): 59-82
50. Mori, T. A., Omega-3 fatty acids and blood pressure. Cell. Mol. Biol. 2010, 56(1): 83-92
51. 2-macroglobulin in healthy subjects after supplementation with different doses of marine n-3 fatty acids. Cell. Mol. Biol. 2010, 56(1): 102-109
52. Marchioli, R., Silletta, M.G., Levantesi, G., Pioggiarella, R., Tognoni, G., N-3 polyunsaturated fatty acids in heart failure: mechanisms and recent clinical evidence. Cell. Mol. Biol. 2010, 56(1): 110-130
53. Christensen, J.H., Svensson, M., Strandhave, C, Madsen, T., Schmidt, E.B., N-3 fatty acids and cardiac autonomic function in humans. Cell. Mol. Biol. 2010, 56(1): 131-139